1GALE Stock Overview

Operates as a healthcare service provider in Switzerland and internationally. More details

1GALE fundamental analysis
Snowflake Score
Valuation	2/6
Future Growth	1/6
Past Performance	4/6
Financial Health	6/6
Dividends	3/6

Rewards

Trading at 45.2% below our estimate of its fair value

Earnings are forecast to grow 4.56% per year

Earnings have grown 3.7% per year over the past 5 years

Risk Analysis

Shares are highly illiquid

Community vs My Fair Value

Create Narrative

Select a narrative for quick price alerts from the community, or create your own.

Galenica AG Competitors

Amplifon

BIT:AMP

€4.4b

DiaSorin

BIT:DIA

€5.1b

Guangzhou Baiyunshan Pharmaceutical Holdings

SEHK:874

HK$44.6b

EL.En

BIT:ELN

€818.1m

Price History & Performance

Summary of share price highs, lows and changes for Galenica
Historical stock prices
Current Share Price	CHF 93.00
52 Week High	CHF 0
52 Week Low	CHF 0
Beta	0.29
1 Month Change	n/a
3 Month Change	n/a
1 Year Change	n/a
3 Year Change	n/a
5 Year Change	n/a
Change since IPO	1.09%

Recent News & Updates

No updates

Recent updates

No updates

Shareholder Returns

	1GALE	IT Healthcare	IT Market
7D	1.1%	4.7%	2.9%
1Y	n/a	17.2%	14.1%

Return vs Industry: Insufficient data to determine how 1GALE performed against the Italian Healthcare industry.

Return vs Market: Insufficient data to determine how 1GALE performed against the Italian Market.

Price Volatility

Is 1GALE's price volatile compared to industry and market?
1GALE volatility
1GALE Average Weekly Movement	n/a
Healthcare Industry Average Movement	5.5%
Market Average Movement	5.5%
10% most volatile stocks in IT Market	8.7%
10% least volatile stocks in IT Market	3.4%

Stable Share Price: 1GALE's share price has been volatile over the past 3 months compared to the Italian market.

Volatility Over Time: Insufficient data to determine 1GALE's volatility change over the past year.

About the Company

Founded	Employees	CEO	Website
1927	6,241	Marc Werner	www.galenica.com

Galenica AG operates as a healthcare service provider in Switzerland and internationally. It operates in two segments, Products & Care, and Logistics & IT. The Products & Care segment operates pharmacies and partner pharmacies under the Amavita, Sun Store, and Coop Vitality brands, as well as covers specialty pharmacy mediservice.

Galenica AG Fundamentals Summary

How do Galenica's earnings and revenue compare to its market cap?
1GALE fundamental statistics
Market cap	€4.60b
Earnings (TTM)	€195.63m
Revenue (TTM)	€4.20b

23.5x

P/E Ratio

1.1x

P/S Ratio

Is 1GALE overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
1GALE income statement (TTM)
Revenue	CHF 3.93b
Cost of Revenue	CHF 3.46b
Gross Profit	CHF 472.15m
Other Expenses	CHF 289.12m
Earnings	CHF 183.03m

Last Reported Earnings

Dec 31, 2024

Next Earnings Date

Aug 07, 2025

Earnings per share (EPS)	3.67
Gross Margin	12.01%
Net Profit Margin	4.66%
Debt/Equity Ratio	36.0%

How did 1GALE perform over the long term?

See historical performance and comparison

Dividends

2.7%

Current Dividend Yield

63%

Payout Ratio

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2025/05/18 18:05
End of Day Share Price	2025/05/16 00:00
Earnings	2024/12/31
Annual Earnings	2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Galenica AG is covered by 7 analysts. 4 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution
Alexander Berglund	BofA Global Research
Christoph Gretler	Credit Suisse
Yi-Dan Wang	Deutsche Bank